Home Subjects Market

Market

AstraZeneca receives marketing permission for Durvalumab (ImfinziTM) in India

Durvalumabis the only immunotherapy approved for patients with unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) Durvalumabwas granted US FDA ‘breakthrough therapy’ designationon July 31, 2017. Bengaluru, June 25, 2018: AstraZeneca Pharma India Limited(AZPIL)today announced that it has received...

Singapore Medical and Dental Clinics Market Outlook to 2022-Ken Research

New Delhi, June 24, 2018: The report titled “Singapore Medical and Dental Clinics Market Outlook to 2022 – Led by Inorganic Expansion of Major Clinics and Expansion into More Specialized Services” covers dental and medical clinics market segment by...

Attendance rise sees CPhI & P-MEC India 2018 move to Indian capital

The India Expo Mart brings the event closer to Indian regulatory and legislative hub and will encourage international audiences  Amsterdam, June 15, 2018:  CPhI & P-MEC India (December 10-14, 2018) – organised by UBM – announces that the 12th edition of Asia's largest Pharma exhibition...

Global Onychomycosis Drug Market 2018 Opportunities: J&J, Torrent Pharma, Chengdu Brilliant and Yangtze River

New Delhi, June 11, 2018:  Global Onychomycosis Drug research report offers an expert and thorough analysis of the present condition alongside competitive scenario, Onychomycosis Drug share and forecast by 2023. The report presents the fundamentals: definitions, characterizations, applications and Onychomycosis...

INDIA RATINGS – Pharmaceutical Formulators Diverge on Strategy for Non-Prescription Businesses

Mumbai, April 21, 2018: India Ratings and Research (Ind-Ra) expects Indian formulators to continue to make investments to grow their domestic non-prescription business through organic and inorganic routes. This would be driven by the need to further diversify the domestic...

USFDA conducts cGMP audit at Cipla’s Indore formulations facility

Mumbai, April 21,2018: Pharma Major, Cipla Ltd ssaid that US Food and Drug Administration (USFDA) has conducted a routine current Good Manufacturing Practices (cGMP) audit at Company's Indore formulations facility from April 2, 2018 till April 13, 2018.  This was in the...

NutriParadise Successfully Serves More Than 1.5 lakh Patients Since Inception

Bengaluru, April 2018: NutriParadise, Foods India's pioneering company to develop and supply convenient therapeutic food products for hospitalized people, has achieved the milestone of serving more than 1.5 lakh people since its inception. The Bengaluru-headquartered startup, incubated by CFTRI, is the first-of-its-kind company that...

Hearing Implants Market in France to Balloon via Positive Economic Changes: Ken Research

New Delhi, April 19, 2018: Hearing implants are generally used when the conventional hearing aids are unable to generate benefits. These implants are basically the surgical devices that produce a sensation of sound and are designed in accordance with...

Buy Torrent Pharmaceuticals, target Rs 1,560: IIFL

IIFL has a buy call on Torrent Pharmaceuticals with a target price of Rs 1,560. The current market price of Torrent Pharmaceuticals is Rs 1,303.40. Time period given by the brokerage is one year when Torrent Pharmaceuticals price can reach the...

Natural and Organic Cosmetics to Drive the Growth in Global Cosmeceuticals Industry: Ken Research

New Delhi, April 04, 2018: Cosmeceuticals products are cosmetic products with biologically active ingredients with medical or drug-like benefits. Cosmeceuticals are used in the treatment of acne vulgaris, atopic dermatitis, and skin aging and hyper-pigmentation. In the field of...